Metabolite Delivery Platform (Therapeutic Programs)
Inflammatory Bowel Disease (IBD)
Key Facts
About ClostraBio
ClostraBio is focused on restoring intestinal barrier-protective function and innate immunity to maintain gut health and treat diseases of the gut and food allergy. The company leverages a well-rounded team of scientists and entrepreneurs with expertise in microbiology and bioengineering to develop both a dietary supplement and a versatile delivery platform. Their core technology aims to transform intestinal health through targeted metabolite delivery, addressing significant unmet needs in the IBD and food allergy markets.
View full company profileAbout ClostraBio
ClostraBio is focused on restoring intestinal barrier-protective function and innate immunity to maintain gut health and treat diseases of the gut and food allergy. The company leverages a well-rounded team of scientists and entrepreneurs with expertise in microbiology and bioengineering to develop both a dietary supplement and a versatile delivery platform. Their core technology aims to transform intestinal health through targeted metabolite delivery, addressing significant unmet needs in the IBD and food allergy markets.
View full company profileTherapeutic Areas
Other Inflammatory Bowel Disease (IBD) Drugs
| Drug | Company | Phase |
|---|---|---|
| DFTX-201 | Definium Therapeutics | Preclinical |
| COSMO-232 | Cosmo Pharmaceuticals | Preclinical |
| Tamuzimod | Ventyx Biosciences | Phase 2 |
| VTX958 | Ventyx Biosciences | Phase 2 |
| GPR35 Agonist | Nxera Pharma | Preclinical |
| SL-325 | Shattuck Labs | Phase 2 |
| SL-425 | Shattuck Labs | Phase 1 |
| ABS-101 | AbSci | Pre-clinical |
| ABO21009 | AboleIIs Pharma | Phase 1 |